India has secured a notable achievement in the global APIs market competition,
In 2023, the US Food and Drug Administration’s Center for Drug Evaluation and Research
The future of Active Pharmaceutical Ingredients (APIs) holds significant promise and challenges
In 2023, generic-drug approvals in the US surged to a recent peak, although the number of
In the realm of pharmaceuticals, green is emerging as the new standard
The active pharmaceutical ingredients (API) market witnessed
The landscape for Contract Development and Manufacturing Organizations
The global pharmaceutical sector is extensive, encompassing two primary segments: Active Pharmaceutical
Eli Lilly and Company have announced a monumental expansion of its Lebanon
Amidst the trials brought forth by the Covid-19 pandemic, the pharmaceutical